Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid-lowering therapy.
Hiroyuki YamamotoToshiro ShinkeHiromasa OtakeHiroyuki KawamoriTakayoshi TobaMasaru KurodaYushi HirotaKazuhiko SakaguchiWataru OgawaKen-Ichi HirataPublished in: Journal of diabetes investigation (2020)
Daily GF might influence future CVE in lipid-controlled stable CAD patients.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- end stage renal disease
- coronary artery bypass grafting
- acute myocardial infarction
- physical activity
- newly diagnosed
- ejection fraction
- acute coronary syndrome
- chronic kidney disease
- st segment elevation myocardial infarction
- fatty acid
- peritoneal dialysis
- st elevation myocardial infarction
- cardiovascular events
- antiplatelet therapy
- cardiovascular disease
- blood pressure
- stem cells
- heart failure
- atrial fibrillation
- current status
- adipose tissue
- patient reported outcomes
- smoking cessation
- left ventricular
- aortic valve
- patient reported
- coronary artery bypass